Synthesis and biological evaluation of dual action cyclo-RGD/SMAC mimetic conjugates targeting αvβ3/αvβ5 integrins and IAP proteins
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis and biological evaluation of dual action cyclo-RGD/SMAC mimetic conjugates targeting αvβ3/αvβ5 integrins and IAP proteins
Authors
Keywords
-
Journal
ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 12, Issue 20, Pages 3288-3302
Publisher
Royal Society of Chemistry (RSC)
Online
2014-03-21
DOI
10.1039/c4ob00207e
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design, Synthesis, and Biological Evaluation of Novel cRGD–Paclitaxel Conjugates for Integrin-Assisted Drug Delivery
- (2012) Michael Pilkington-Miksa et al. BIOCONJUGATE CHEMISTRY
- Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization
- (2012) Daniele Lecis et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Rational design, synthesis and characterization of potent, drug-like monomeric Smac mimetics as pro-apoptotic anticancer agents
- (2012) Aldo Bianchi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer
- (2012) X. Wen et al. CELL PROLIFERATION
- Cyclic RGD Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands
- (2012) Mattia Marchini et al. CHEMISTRY-A EUROPEAN JOURNAL
- Synthesis and Biological Evaluation (in Vitro and in Vivo) of Cyclic Arginine–Glycine–Aspartate (RGD) Peptidomimetic–Paclitaxel Conjugates Targeting Integrin αVβ3
- (2012) Raffaele Colombo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)
- (2012) John A. Flygare et al. JOURNAL OF MEDICINAL CHEMISTRY
- A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein
- (2012) Donatella Potenza et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Integrin Targeted Delivery of Chemotherapeutics
- (2012) Kai Chen et al. Theranostics
- A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment
- (2011) Qian Cai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Aliskiren
- (2010) Sean T. Duggan et al. DRUGS
- Apoptosis in cancer: Key molecular signaling pathways and therapy targets
- (2009) Claudia Burz et al. ACTA ONCOLOGICA
- Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy
- (2009) Pierfausto Seneci et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Cyclic RGD-Containing Functionalized Azabicycloalkane Peptides as Potent Integrin Antagonists for Tumor Targeting
- (2009) Leonardo Manzoni et al. ChemMedChem
- Design and characterization of bivalent Smac-based peptides as antagonists of XIAP and development and validation of a fluorescence polarization assay for XIAP containing both BIR2 and BIR3 domains
- (2007) Zaneta Nikolovska-Coleska et al. ANALYTICAL BIOCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now